JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Skyward Specialty Files Registration Statement for Initial Public Offering
-
Skyward Specialty Files Registration Statement for Initial Public Offering
-
Skyward Specialty Files Registration Statement for Initial Public Offering
-
Skyward Specialty Insurance Group (SKWD) Announces Proposed IPO
-
UPDATE: JMP Securities Starts Sachem Capital Corp. (SACH) at Market Perform
-
Blueprint Medicines to Present at Upcoming Investor Conferences
-
Allogene Therapeutics To Host Research & Development Showcase and Participate in Five Upcoming Investor Conferences
-
Allogene Therapeutics To Host Research & Development Showcase and Participate in Five Upcoming Investor Conferences
-
Carvana (CVNA) Sell-Off on Liquidity Worries 'Overdone', PT to $25 - JMP Securities
-
OutSystems Acquires Ionic to Unite the Power of Open Source Mobile Development with High-Performance Low-Code
-
Western Asset Mortgage Capital Corporation Announces Third Quarter 2022 Results
-
Big Tech tumbles as results set off alarm bells
-
Spirit Realty Capital (SRC) PT Lowered to $49 at JMP Securities
-
UPDATE: JMP Securities Upgrades ShotSpotter (SSTI) to Market Outperform
-
UPDATE: JMP Securities Starts Orion Office REIT Inc (ONL) at Market Perform
-
UPDATE: JMP Securities Starts Exelixis (EXEL) at Market Outperform
-
UPDATE: JMP Securities Starts Benitec BioPharma (BNTC) at Market Outperform
-
JMP Securities Upgrades Athira Pharma (ATHA) to Market Outperform
-
JMP Securities Downgrades Minerva Neurosciences (NERV) to Market Perform
-
Braze, Inc. (BRZE) Shares Fall Following Analyst Day
-
Ares Commercial (ACRE) PT Lowered to $13.50 at JMP Securities
-
GATC Health Investor Conference to Feature First Public Demonstration of Its AI Platform's Drug Discovery Capabilities
-
Lumotive and Gpixel Jointly Unveil M30 Lidar Sensor Reference Design Platform for High-Volume Mobility and Industrial Applications
-
Lumotive and Gpixel Jointly Unveil M30 Lidar Sensor Reference Design Platform for High-Volume Mobility and Industrial Applications
-
Peloton taps Dick's Sporting Goods stores to sell exercise bikes, treadmills
-
JMP Securities Starts Nexpoint Real Estate (NREF) at Market Perform
-
Idera Pharma (IDRA) Acquires Aceragen
-
Idera Pharmaceuticals Acquires Aceragen
-
Gamida Cell Ltd. (GMDA) Prices 12.9M Share Offering at $1.55/sh
-
Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares
-
Gamida Cell Ltd. (GMDA) Launches Share Offering, Size not Disclosed
-
Gamida Cell Announces Launch of Public Offering of Ordinary Shares
-
UPDATE: JMP Securities Starts Dynavax Technologies (DVAX) at Market Outperform
-
Liberty Star Announces Changes to The Board of Directors
-
Liberty Star Announces Changes to The Board of Directors
-
UPDATE: JMP Securities Starts Gaming and Leisure (GLPI) at Market Outperform
-
UPDATE: JMP Securities Starts Boyd Gaming (BYD) at Market Outperform
-
Falkonry Unveils GPU-Based, High-Speed Time Series Anomaly Detection Application
-
UPDATE: JMP Securities Starts Red Rock Resorts (RRR) at Market Outperform
-
UPDATE: JMP Securities Starts NexPoint Residential Trust (NXRT) at Market Outperform
-
Larimar Therapeutics Announces Closing of Underwritten Offering and Full Exercise of Option to Purchase Additional Shares
-
Benitec Biopharma Inc. Announces Closing of $18 Million Underwritten Public Offering
-
UPDATE: JMP Securities Starts Lava Therapeutics NV (LVTX) at Market Outperform
-
UPDATE: JMP Securities Starts BioAtla Inc. (BCAB) at Market Outperform
-
Larimar Therapeutics (LRMR) Announces $70 Million Underwritten Offering of Common Stock
-
Larimar Therapeutics Announces $70 Million Underwritten Offering
-
Bow River Capital's Software Growth Equity Team Makes Majority Platform Investment in HRSoft, a Human Capital Management SaaS Market Leader in Compensation Management
-
Benitec Biopharma (BNTC) Prices 29.8M Share Offering at $0.60/sh
-
Benitec Biopharma Inc. Announces Pricing of $18 Million Underwritten Public Offering
-
Whitestone REIT (WSR) enters into equity distribution agreements

